The 2016 Harvard FUSION symposium, a celebration of scientific advancement and economic development, explored the future of regenerative medicine and the business models that will bring life-changing innovations to patients.Watch the Highlights
Lawrence H. Summers
Charles W. Eliot University Professor and President Emeritus, Harvard University
What advances are at the leading edge of regenerative medicine today? What challenges remain for the field, and what areas of application have yet to be explored?
Will new types of business models and organizational structures be needed to bring regenerative medicine products and services to patients?
Douglas A. Melton
Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University; co-director of the Harvard Stem Cell Institute; and scientific founder of Semma Therapeutics
We know that science on its own can provide tremendous insights and improvements in the qualify of life.
We also know that the marriage of science to real enterprise can create the infrastructure that brings society products of transformative value.
Professor of Management Practice, Harvard Business School
When Lawrence Summers delivered his last commencement address as Harvard’s president 10 years ago, he spoke of the rosy future for stem cell science and regenerative medicine.
The advancing technology, he said then, promised a cure for cancer, another for diabetes, a vaccine for Alzheimer’s disease, and ways to control AIDS, any one of which would have enormous impact around the world. Today, he believes he was too pessimistic...Read More
Many thanks to our 2016 FUSION event sponsors